Medical marijuana is set to become a hot area in the pharmaceutical industry in the coming years. The use of cannabis-based medication has been a subject of debate for some time, but the merits of medical marijuana heavily outweigh the negatives.
Through GlobalData’s in-depth thematic research you will be able to strengthen your understanding of the medical marijuana market. Follow the US, France, Germany, Italy, Spain, UK, Canada, Israel, and Australia as they continue to invest in medical marijuana products and CBD oil. Due to this area being so new, the market will sharply rise at the CAGR of 81.3% between 2018 and 2025 reaching a value of $3.2bn.